Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Dow
Chubb
Covington
McKesson
Express Scripts
Fish and Richardson
Novartis
QuintilesIMS
Mallinckrodt

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072265

« Back to Dashboard

NDA 072265 describes BENZTROPINE MESYLATE, which is a drug marketed by Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Navinta Llc, Anda Repository, Aspen Global Inc, Epic Pharma Llc, Invagen Pharms, Lannett Holdings Inc, Leading Pharma Llc, Oxford Pharms, Pliva, Quantum Pharmics, Usl Pharma, and Vintage, and is included in twenty-seven NDAs. It is available from thirty-one suppliers. Additional details are available on the BENZTROPINE MESYLATE profile page.

The generic ingredient in BENZTROPINE MESYLATE is benztropine mesylate. There are five drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the benztropine mesylate profile page.
Summary for 072265
Tradename:BENZTROPINE MESYLATE
Applicant:Epic Pharma Llc
Ingredient:benztropine mesylate
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 072265
Medical Subject Heading (MeSH) Categories for 072265
Suppliers and Packaging for NDA: 072265
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 072265 ANDA Major Pharmaceuticals 0904-1056 0904-1056-61 100 TABLET in 1 BOX, UNIT-DOSE (0904-1056-61)
BENZTROPINE MESYLATE benztropine mesylate TABLET;ORAL 072265 ANDA Major Pharmaceuticals 0904-1056 0904-1056-80 1000 TABLET in 1 BOTTLE (0904-1056-80)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Feb 27, 1989TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Novartis
Boehringer Ingelheim
Chinese Patent Office
Moodys
Julphar
Federal Trade Commission
QuintilesIMS
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot